mitoxantrone has been researched along with Pneumonia in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose chemotherapy given with autologous bone marrow support has resulted in significant tumor responses in the majority of patients with metastatic breast cancer, a minority of which are durable." | 6.67 | Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer. ( Adkins, D; Bowers, C; Dunphy, F; Harrison, B; LeMaistre, CF; Spitzer, G, 1993) |
| "High-dose chemotherapy given with autologous bone marrow support has resulted in significant tumor responses in the majority of patients with metastatic breast cancer, a minority of which are durable." | 2.67 | Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer. ( Adkins, D; Bowers, C; Dunphy, F; Harrison, B; LeMaistre, CF; Spitzer, G, 1993) |
| "We describe two cases of interstitial lung disease in patients with non-Hodgkin's lymphoma who were treated with combination chemotherapy including mitozantrone." | 1.30 | Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy. ( Johnson, S; Nicholson, AG; Rule, S; Stone, R; Tighe, M; Tomlinson, J, 1999) |
| "We describe a case of pneumonitis in a patient receiving selective intra-arterial chemotherapy for locally advanced breast cancer." | 1.29 | Pneumonitis complicating selective intra-arterial chemotherapy for locally advanced breast carcinoma. ( Doughty, JC; Kane, E; McArdle, CS; McCarter, DH; McLean, AD; Reid, AW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vahid, B | 1 |
| Marik, PE | 1 |
| Bowers, C | 1 |
| Adkins, D | 1 |
| Dunphy, F | 1 |
| Harrison, B | 1 |
| LeMaistre, CF | 1 |
| Spitzer, G | 1 |
| McLean, AD | 1 |
| Doughty, JC | 1 |
| Reid, AW | 1 |
| McCarter, DH | 1 |
| Kane, E | 1 |
| McArdle, CS | 1 |
| Tomlinson, J | 1 |
| Tighe, M | 1 |
| Johnson, S | 1 |
| Stone, R | 1 |
| Nicholson, AG | 1 |
| Rule, S | 1 |
1 review available for mitoxantrone and Pneumonia
| Article | Year |
|---|---|
Pulmonary complications of novel antineoplastic agents for solid tumors.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetaboli | 2008 |
1 trial available for mitoxantrone and Pneumonia
| Article | Year |
|---|---|
Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer.
Topics: Adult; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Dose-R | 1993 |
2 other studies available for mitoxantrone and Pneumonia
| Article | Year |
|---|---|
Pneumonitis complicating selective intra-arterial chemotherapy for locally advanced breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Infusions, | 1996 |
Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; H | 1999 |